ES2286509T3 - Derivados del acido halotenoil-ciclopropano-1-carboxilico. - Google Patents

Derivados del acido halotenoil-ciclopropano-1-carboxilico. Download PDF

Info

Publication number
ES2286509T3
ES2286509T3 ES03811772T ES03811772T ES2286509T3 ES 2286509 T3 ES2286509 T3 ES 2286509T3 ES 03811772 T ES03811772 T ES 03811772T ES 03811772 T ES03811772 T ES 03811772T ES 2286509 T3 ES2286509 T3 ES 2286509T3
Authority
ES
Spain
Prior art keywords
cyclopropane
tenoyl
chloro
carboxylate
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03811772T
Other languages
English (en)
Spanish (es)
Inventor
Luca Benatti
Ruggero Fariello
Patricia Salvati
Roberto Pellicciari
Carla Caccia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newron Pharmaceuticals SpA
Original Assignee
Newron Pharmaceuticals SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharmaceuticals SpA filed Critical Newron Pharmaceuticals SpA
Application granted granted Critical
Publication of ES2286509T3 publication Critical patent/ES2286509T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES03811772T 2002-11-28 2003-11-25 Derivados del acido halotenoil-ciclopropano-1-carboxilico. Expired - Lifetime ES2286509T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026597 2002-11-28
EP02026597A EP1424333A1 (en) 2002-11-28 2002-11-28 Halothenoyl-cyclopropane-1-carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
ES2286509T3 true ES2286509T3 (es) 2007-12-01

Family

ID=32241303

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03811772T Expired - Lifetime ES2286509T3 (es) 2002-11-28 2003-11-25 Derivados del acido halotenoil-ciclopropano-1-carboxilico.

Country Status (13)

Country Link
US (1) US20060116329A1 (https=)
EP (2) EP1424333A1 (https=)
JP (1) JP4522864B2 (https=)
AT (1) ATE361921T1 (https=)
AU (1) AU2003296596B2 (https=)
CA (1) CA2507597A1 (https=)
CY (1) CY1106692T1 (https=)
DE (1) DE60313798T2 (https=)
DK (1) DK1565451T3 (https=)
ES (1) ES2286509T3 (https=)
PT (1) PT1565451E (https=)
SI (1) SI1565451T1 (https=)
WO (1) WO2004048361A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1475088A1 (en) * 2003-05-05 2004-11-10 Newron Pharmaceuticals S.p.A. Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract
GB2402940A (en) * 2004-08-19 2004-12-22 Pfizer Ltd Biomarkers of inflammation and/or macrophage activation
JP2008535892A (ja) * 2005-04-11 2008-09-04 プロビオドルグ エージー プロリルエンドペプチダーゼの阻害剤
WO2012175513A1 (en) 2011-06-20 2012-12-27 Bayer Intellectual Property Gmbh Thienylpyri(mi)dinylpyrazole
EP3130583B1 (en) 2012-04-05 2024-01-03 CHDI Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
ES2754473T3 (es) * 2013-09-26 2020-04-17 Chdi Foundation Inc Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas, y método de uso de los mismos
US9884853B2 (en) 2013-09-26 2018-02-06 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
GB201322512D0 (en) 2013-12-19 2014-02-05 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201508864D0 (en) 2015-05-22 2015-07-01 Glaxosmithkline Ip Dev Ltd Compounds
GB201508857D0 (en) 2015-05-22 2015-07-01 Glaxosmithkline Ip Dev Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1278435B (de) * 1965-01-19 1968-09-26 Merck Ag E Verfahren zur Herstellung von 1, 2-disubstituierten Cyclopropanderivaten
US4022903A (en) * 1975-06-05 1977-05-10 Abbott Laboratories α-Thienyl and α-substituted thienyl, phenyl and substituted phenyl cyclopropylomethanols useful as biodegradable insecticides and mollusicides
US6274590B1 (en) * 1993-01-15 2001-08-14 G. D. Searle & Co. Method of treating skin related conditions
JP4176150B2 (ja) * 1996-10-30 2008-11-05 塩野義製薬株式会社 グルタミン酸放出阻害剤および新規化合物
GB9705031D0 (en) * 1997-03-11 1997-04-30 Pharmacia & Upjohn Spa 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives

Also Published As

Publication number Publication date
JP4522864B2 (ja) 2010-08-11
DE60313798T2 (de) 2008-01-24
DE60313798D1 (en) 2007-06-21
EP1565451A1 (en) 2005-08-24
PT1565451E (pt) 2007-08-03
US20060116329A1 (en) 2006-06-01
ATE361921T1 (de) 2007-06-15
DK1565451T3 (da) 2007-09-10
EP1565451B1 (en) 2007-05-09
SI1565451T1 (sl) 2007-08-31
CA2507597A1 (en) 2004-06-10
EP1424333A1 (en) 2004-06-02
AU2003296596B2 (en) 2010-03-04
AU2003296596A1 (en) 2004-06-18
WO2004048361A1 (en) 2004-06-10
JP2006509753A (ja) 2006-03-23
CY1106692T1 (el) 2012-05-23

Similar Documents

Publication Publication Date Title
CA3019663C (en) IVACAFTOR ANALOGUES CONTAINING SILICONE ATOMS
ES2972419T3 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
CN103140227B (zh) 制备微管蛋白细胞溶素的方法
CA2545813C (en) The derivatives of pyridone and use thereof
ES2286509T3 (es) Derivados del acido halotenoil-ciclopropano-1-carboxilico.
JP6393754B2 (ja) カロテノイド誘導体、その薬学上許容される塩又はその薬学上許容されるエステル類若しくはアミド類
ES2312808T3 (es) Derivados de dioxano-2-alquilcarbamatos, su preparacion y su aplicacion en terapeutica.
KR100400507B1 (ko) 치환 피롤리딘 히드록사메이트 메탈로프로테아제 억제제
ES2543956T3 (es) Derivados de piridinona como inhibidores de transglutaminasa tisular
CA3000483A1 (en) Compounds, compositions, and methods for modulating cftr
JPH09512798A (ja) 消炎、鎮痛および抗血栓活性を有するニトロ化合物およびそれらの組成物
ES2228587T3 (es) Retinoides para el tratamiento de enfisema.
JP2001513767A (ja) メタロプロテアーゼ阻害剤としての逆ヒドロキサメート誘導体
JP2004502775A (ja) 非ヌクレオシド逆転写阻害剤抗レトロウイルス療法をモニターするための手段および方法
ES2334574T3 (es) Compuestos de tipo hidrazida y su uso en unas composiciones farmaceuticas para el tratamiento de las enfermedades cardiovasculares.
HU199801B (en) Process for producing pyridine-2,4- and -2,5-dicarboxylic acid derivatives and pharmaceutical compositions comprising such compounds
EP1475385A1 (en) Glycoside derivatives of 2-(3,4-dichlorobenzoyl)-cycopropane-1-carboxylic acid
WO2021113808A1 (en) Cftr-modulating arylamides
KR20220004963A (ko) 카스파제 억제제 및 이의 사용 방법
WO1994012527A1 (en) Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same
CN116669744B (zh) Nrf2活化化合物
JPH10231285A (ja) フタルイミド誘導体又はその塩、それらの製造方法及びそれらを含有する医薬組成物
KR920006784B1 (ko) 소염성 1-헤테로아릴-옥신돌-3-카복스아미드
ES2204300B1 (es) Nuevos derivados del acido 2,4-dihidroxibenzoico.
CN110117301A (zh) 用于防治神经退行性疾病的新化合物及其应用